CoolSculpting® by Zeltiq
When it comes to eliminating unwanted fat on the body, our dermatology practices have the advanced technology that can do the job – without surgery. Developed by ZELTIQ®, CoolSculpting® in our Miami area offices, is a breakthrough, FDA-cleared, non-invasive procedure that gently and effectively reduces areas of unwanted fat. A single treatment provides noticeable, natural looking fat reduction in the treated areas for men and women of all ages and skin types. At our offices all the procedures including CoolSculpting are personally performed by the physicians.
Slimmer Without Surgery
CoolSculpting’s unique cooling technology targets and eliminates fat cells permanently and naturally to create a 20 to 25% fat layer reduction in common trouble spots such as the abdomen, love handles and back fat. Developed by a team of scientists and physicians, CoolSculpting utilizes a precisely controlled cooling method called Cryolipolysis to target, cool, and eliminate fat cells without damage to other tissue.
Your Treatment
CoolSculpting is a simple office procedure that is personally performed by one of our board-certified dermatologists. During treatment the device emits intense cold into the targeted area to crystalize the fat cells. The cold feeling usually dissipates quickly and pain medication is not required. After about an hour, the device is moved to another area, for example, from one love handle to the other. Most people spend from 1 to 3 hours for a complete CoolSculpting procedure.
Afterwards, there is no downtime required, so you can work and exercise without restriction. While the most noticeable slimming takes place between 8 and 12 weeks after a CoolSculpting procedure, treated fat cells may be eliminated by the body’s natural processes for up to 6 months. Ultherapy® skin tightening treatments can further improve results.
CoolSculpting achieves noticeable results without special diet supplements or additional exercise. The results are long lasting and maintained with your current lifestyle.